Monday, January 28, 2013

The “Deanna Protocol” Being Studied and Tried: “By Me”

Here’s some information I’m looking at and researching… and testing

I’m in my second week (as of 1/28/2013), but am ramping doses slowly to avoid stomach or bowel issues. There’s a lot of high dose anti-oxidants in this regimen..

Here’s the welcome letter from the creator…


Here’s what I started with the 1st 2 weeks ($300 later for a calculated 60 day trial)….

  • Glycine 500mg 1x/day
  • AAKG 7g 1x/day
  • NADH 20g 1x/day
  • GABA 250mg 1x/day
  • Glutathione 250mg 1x/day
  • Ubiquinol 200mg 1x/day
  • CoQ-10 200 mg 1x/day
  • Methyl B-12 complex 5000mcg 1x/day

(partial listing…. for now)

items already being taken:

  • Clonazopam 1.5mg night
  • Baclofen 10mg 2x/day
  • Zoloft 50mg
  • Robinol 1mg




next level to be started 2/4/2013  (changes in red)

  • Glycine 500mg 2x/day
  • AAKG 10g 1x/day
  • NADH 20g 2x/day
  • GABA 250mg 2x/day
  • Glutathione 500mg 1x/day
  • Ubiquinol 200mg 1x/day
  • CoQ-10 400mg 1x/day
  • Methyl B-12 complex 5000mcg 1x/day

Friday, January 04, 2013

Phase 3 Trial of Dexpramipexole in ALS Fails to Show Benefit

images (1)

Unfortunately, Biogen Idec has announced that the experimental ALS drug has not shown efficacy in a large-scale trial; its development will be discontinued
Article Highlights:
Dexpramipexole, an experimental drug for amyotrophic lateral sclerosis (ALS), had shown encouraging results in a phase 2 trial but did not continue to show promise in a phase 3 trial.
Biogen Idec will discontinue its dexpramipexole development program; the company has provided phone numbers for people who want more information.
Biogen Idec will continue to pursue other ALS-related research.
To learn more, read the full ALS News Online article. here